5-fluorouracil

Documents about 5-fluorouracil

• Pre-operative 5-Fluorouracil (5-FU) and Sorafenib With External Radiation in Locally Advanced Rectal Cancer#893693ClinicalTrials.gov
• Comparative efficacy of intralesional therapies for keloid scars: a network meta-analysis#4529Europe PMC
• Proton Radiotherapy for Upper Gastrointestinal Malignancies#885095ClinicalTrials.gov
• A Phase II Study of Combine Modality Therapy in Locally Advanced Pancreatic Cancer#901566ClinicalTrials.gov
• Efficacy and Safety Assessment of 5-Fluorouracil, Irinotecan and Oxaliplatin-Loaded Implants in Mouse and Pig Models for Pancreatic Cancer Therapy.#165740NCBI PubMed Central
• Protective Role of Alpha-Lipoic Acid in Chemotherapy-Induced Mucositis#902861ClinicalTrials.gov
• Combination Therapy With 5-Fluorouracil and Photodynamic Therapy in Post-transplant Premalignant Skin Disease#918490ClinicalTrials.gov
• Liposomes containing sorbitan monolaurate incorporated in hydroxyethylcellulose hydrogels for topical delivery of 5-fluorouracil: rheological characterization, skin penetration and cytotoxicity study#255715Repositório Institucional Unesp
• A Genotype-guided Study of Irinotecan Administered in Combination With 5-fluorouracil/Leucovorin (FOLFIRI) and Bevacizumab in Advanced Colorectal Cancer Patients#812304ClinicalTrials.gov
• Oxaliplatin and 5-Fluorouracil With or Without Docetaxel in Elderly Patients (>65 y) With Stomach and Esophagus Cancer#886579ClinicalTrials.gov
• A Study of Cyclophosphamide/Methotrexate/5-Fluorouracil (CMF) With Pegfilgrastim in Subjects With Breast Cancer#894180ClinicalTrials.gov
• A Randomized Trial of Avastin + Gemcitabine + 5-Fluorouracil (5FU)/Folinic Acid Versus Avastin + Oxaliplatin + 5FU/Folinic Acid in Metastatic Colorectal Cancer#981733ClinicalTrials.gov
• Fluoropyrimidine-induced cardiotoxicity: outcomes and safety of chemotherapy reintroduction in a retrospective cohort study#15446HAL (France)
• TGF-β Receptor Inhibitor SB431542 Enhanced the Sensitivity of Gastric Cancer to 5-Fluorouracil: New Combined Targeted Therapy#274720IRIS
• Phase II Neoadjuvant in Inflammatory Breast Cancer#850764ClinicalTrials.gov
• Testing the Efficacy of Topical Calcipotriene Plus 5-Fluorouracil Combination to Activate the Immune System Against Precancerous Skin Lesions in Organ Transplant Recipients#857031ClinicalTrials.gov
• Study of 5-fluorouracil (5-FU), Nab®1-paclitaxel, Bevacizumab, Leucovorin, and Oxaliplatin in Patients With Metastatic Pancreatic Cancer#851394ClinicalTrials.gov
• DPYD Exome, mRNA Expression and Uracil Levels in Early Severe Toxicity to Fluoropyrimidines: An Extreme Phenotype Approach#16764HAL (France)
• Data Management and Sharing Plan for: Expanded Safety and Preliminary Efficacy of Adjuvant 5-Fluorouracil Following Thermal Ablation to Improve HPV Treatment Outcomes in Women with HIV in Africa#263852UNC Dataverse Dataverse OAI Archive
• 5-Fluorouracil modulates motility and biofilm-associated gene expression in <i>Pseudomonas aeruginosa</i>#396694PLOS
• 5-Fluorouracil, Bevacizumab, and Radiation Followed by Modified FOLFOX6 and Bevacizumab in Stage II/III Rectal Cancer#969533ClinicalTrials.gov
• Modufolin (Arfolitixorin) in Combination With 5-Fluorouracil Alone or Together With Oxaliplatin or Irinotecan in Colorectal Cancer#907998ClinicalTrials.gov
• Paclitaxel Followed by FEC Versus Paclitaxel and RAD001 Followed by FEC In Women With Breast Cancer#909205ClinicalTrials.gov
• The Application of Intralesional 5-fluorouracil for the Management of Hypertrophic Facial Scars in the Periocular Region Resulting From Trauma and Surgical Procedures in Individuals Aged Over 18 Years#888413ClinicalTrials.gov
• Liposomal Irinotecan, 5-fluorouracil/Calcium Folinate, Oxaliplatin, and Adebrelimab in Combination With Radiotherapy for Resectable or Borderline Resectable Pancreatic Cancer With Risk Factors：A Prospective Exploratory Study#184873ClinicalTrials.gov
• Development, characterization and evaluation of 5-fluorouracil loaded gold nanoparticles conjugated with cd133 antibody targeting positive-survivin colorectal cancer stem cells#373029USM Repository
• Folfox-B Study for Patients With Colorectal Liver Metastases#848755ClinicalTrials.gov
• Study of Sequential Systemic Therapy + Intraperitoneal Paclitaxel in Gastric/GEJ Peritoneal Carcinomatosis#853249ClinicalTrials.gov
• HAIC Plus PD-1 Antibody vs HAIC Plus Sorafenib for Advanced HCC#912416ClinicalTrials.gov
• HAIC Plus Lenvatinib and PD-1 Antibody Versus HAIC Plus Lenvatinib for Advanced HCC#992472ClinicalTrials.gov
• Impact of Oral Versus Intravenous 5-FU-Based Adjuvant Regimens on Sleep Quality and Depression in Patients With Gastrointestinal Cancers#868463ClinicalTrials.gov
• Neoadjuvant Treatment of Toripalimab Combined With Nab-paclitaxel and Platinum Versus Neoadjuvant Docetaxel Combined With Cisplatin and 5-fluorouracil (DCF) in Esophageal Squamous Cell Carcinoma#889787ClinicalTrials.gov
• EndoTAG-1+GEM vs GEM in Patients With Locally Advanced/Metastatic Pancreatic Adenocarcinoma Failed on FOLFIRINOX#894842ClinicalTrials.gov
• Sotorasib plus panitumumab and 5-fluorouracil in first-line treatment of patients with unresectable KRAS G12C mutated colorectal cancer unfit for a doublet/triplet chemotherapy: ENGIC 01 – PRODIGE 107 – FFCD 2306 – COLOSOTO trial#670104HAL (France)
• Using Positron Emission Tomography to Evaluate the Effects of Bevacizumab on Intra-tumoral Pharmacokinetics of 5-fluorouracil in Metastatic Colorectal Cancer#824902ClinicalTrials.gov
• SAMe in Prevention of Oxaliplatin-associated Liver Injury#807329ClinicalTrials.gov
• A Study to Evaluate the Combination of Cetuximab and Chemotherapy as Neoadjuvant Therapy Followed Concomitant Chemoradiotherapy Plus Cetuximab in Locoregional Esophageal Carcinoma#845260ClinicalTrials.gov
• Testing the Addition of an Anti-Cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (5-Fluorouracil) for Metastatic, Refractory Colorectal Cancer#918559ClinicalTrials.gov
• Study of Combination of Sorafenib With Cisplatin and 5-fluorouracil as First-line Treatment of Recurrence After Radiotherapy Patients Who Failed With Radiotherapy in Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC)#1032952ClinicalTrials.gov
• A Prospective, Randomized, Phase III Trial of FLAC (5-Fluorouracil, Leucovorin, Adriamycin, Cytoxan) Chemotherapy With GM-CSF (Granulocyte-Macrophage Colony-Stimulating Factor) Versus PIXY 321 in Advanced Breast Cancer#881006ClinicalTrials.gov
• Consensus of experts from the Spanish Pharmacogenetics and Pharmacogenomics Society and the Spanish Society of Medical Oncology for the genotyping of DPYD in cancer patients who are candidates for treatment with fluoropyrimidines#379143Repositorio Institucional de la Universidad de Burgos (RIUBU)
• A Study of ASP388B Given by Itself and With Standard Therapies in Participants With Solid Tumors#806826ClinicalTrials.gov
• A Pilot Trial of Sequential Chemotherapy With Antimetabolite Induction, High-Dose Alkylating Agent Consolidation With Peripheral Blood Progenitor Cell Support, and Intensification With Paclitaxel and Doxorubicin for Patients With High-Risk Breast Cancer#813109ClinicalTrials.gov
• A Study of BL-B01D1 in Combination With Tislelizumab ±5-Fluorouracil Versus Platinum-Based Chemotherapy Plus Tislelizumab as First-line Treatment in Patients With Unresectable, Locally Advanced Recurrent or Metastatic Esophageal Squamous Cell Carcinoma(PANKU-Esophagus02)#909537ClinicalTrials.gov
• Optimal Control of Liver Metastases From Colorectal Cancer With Cetuximab and Hepatic Artery Infusion of Chemotherapy#806354ClinicalTrials.gov